Skip to main content
Home
FULL MENU Close Menu
Home
Home

Jennifer Kelly Shepphird

News

Prostate cancer screening for men over 50 has declined

Author:
Jennifer Kelly Shepphird
Publish date: June 8, 2015

Key clinical point: Prostate cancer screening rates among men aged 50 years and older declined nationwide from 2010 to 2013. Major finding: From...

  • Read More

News

CD8 cell dose predicts outcomes in allogeneic stem cell transplantation with reduced-intensity conditioning

Author:
Jennifer Kelly Shepphird
Publish date: June 8, 2015

Key clinical point: High CD8 cell dose in peripheral blood stem cell grafts was associated with reduced risk of relapse and increased survival in...

  • Read More

News

T-VEC improved durable response rate in advanced melanoma

Author:
Jennifer Kelly Shepphird
Publish date: May 26, 2015

Key clinical point: Compared with granulocyte-macrophage colony-stimulating factor, talimogene laherparepvec significantly improved durable...

  • Read More

News

Dexrazoxane Tx did not affect overall survival in pediatric leukemia and lymphoma

Author:
Jennifer Kelly Shepphird
Publish date: May 26, 2015

Key clinical point: Treatment with dexrazoxane was not associated with an increased risk for cancer relapse or death. Major finding: For pediatric...

  • Read More

News

ACOG spells out risk assessment for hereditary cancer syndromes

Author:
Jennifer Kelly Shepphird
Publish date: May 21, 2015

  • Read More

News

Oral cancer survival lower with positive margins, public insurance

Author:
Jennifer Kelly Shepphird
Publish date: May 14, 2015

Key clinical point: Treatment factors such as neck dissection, tumor margins, type of insurance, and health care facility impact 5-year survival...

  • Read More

News

Similar 5-year outcomes from accelerated partial-breast irradiation, whole-breast irradiation

Author:
Jennifer Kelly Shepphird
Publish date: May 12, 2015

Key clinical point: Patients with early-stage breast cancer had similar outcomes after 5 years whether they received APBI or WBI . Major finding:...

  • Read More

News

Omega-3 fatty acids similar to placebo for aromatase inhibitor–induced musculoskeletal pain

Author:
Jennifer Kelly Shepphird
Publish date: May 4, 2015

Key clinical point: Patients who received omega-3 fatty acid (O3-FA) capsules, as well as those who received placebo, had significant, sustained...

  • Read More

News

Lung adenocarcinoma subtype predicts benefit from adjuvant chemotherapy

Author:
Jennifer Kelly Shepphird
Publish date: April 27, 2015

Key clinical point: Invasive adenocarcinomas with micropapillary (MIP) and predominantly solid (SOL) patterns had greater benefit from adjuvant...

  • Read More

News

Immunotherapy-related toxicities are varied

Author:
Jennifer Kelly Shepphird
Publish date: April 27, 2015

  • Read More

News

Children with advanced cancer need greater palliative care

Author:
Jennifer Kelly Shepphird
Publish date: April 27, 2015

Key clinical point: According to their own reports, children with advanced cancer experience high suffering, mostly due to cancer-directed therapy...

  • Read More

News

Exercise pumps up chemotherapy completion rates for breast cancer patients

Author:
Jennifer Kelly Shepphird
Publish date: April 27, 2015

Key clinical point: Moderate- to high-intensity exercise during adjuvant chemotherapy improves completion rates.

  • Read More

News

Oophorectomy improves survival after breast cancer in BRCA1 carriers

Author:
Jennifer Kelly Shepphird
Publish date: April 23, 2015

Key clinical point: Oophorectomy significantly improved the prognosis of women with breast cancer and a BRCA1 mutation. Major finding: The...

  • Read More

News

Alzheimer’s drug improves cognitive function after RT for brain tumors

Author:
Jennifer Kelly Shepphird
Publish date: April 20, 2015

Key clinical point: Among adult brain tumor survivors who underwent partial- or whole-brain irradiation, treatment with donepezil compared with...

  • Read More

News

TKI benefit greater with certain EGFR mutations in NSCLC tumors

Author:
Jennifer Kelly Shepphird
Publish date: April 20, 2015

Key clinical point: Risk of non–small cell lung cancer (NSCLC) progression is reduced by 63% for patients with epidermal growth factor receptor (...

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close